Prostate Cancer - Results from #21500

Prostatic carcinosarcoma with lung metastases - Abstract January 4, 2014

An age-corrected matched-pair study of erectile function in patients treated with dose-escalated adaptive image-guided intensity-modulated radiation therapy vs. high-dose-rate brachytherapy for prostate cancer - Abstract January 4, 2014

Salvage brachytherapy for recurrent prostate cancer - Abstract January 4, 2014

Real-world cabazitaxel safety: The Italian early-access program in metastatic castration-resistant prostate cancer - Abstract January 4, 2014

Castrate-resistant prostate cancer with peritoneal metastases treated with docetaxel-based chemotherapy - Abstract January 4, 2014

Osteoblasts stimulate the osteogenic and metastatic progression of castration-resistant prostate cancer in a novel model for in vitro and in vivo studies - Abstract January 3, 2014

Detection of pelvic lymph node micrometastasis by real-time reverse transcriptase polymerase chain reaction in prostate cancer patients after hormonal therapy - Abstract January 3, 2014

Biomarkers in prostate cancer surveillance and screening: Past, present, and future - Abstract January 2, 2014

Considerations for patient selection for focal therapy - Abstract January 2, 2014

Visceral disease in castration-resistant prostate cancer - Abstract January 2, 2014

A multinational, multi-institutional study comparing positive surgical margin rates among 22393 open, laparoscopic, and robot-assisted radical prostatectomy patients - Abstract January 1, 2014

The PICTURE study - prostate imaging (multi-parametric MRI and Prostate HistoScanning™) Compared to Transperineal Ultrasound guided biopsy for significant prostate cancer Risk Evaluation - Abstract January 1, 2014

Nationwide practice patterns for the use of venous thromboembolism prophylaxis among men undergoing radical prostatectomy - Abstract January 1, 2014

Modification of the association between obesity and lethal prostate cancer by TMPRSS2:ERG - Abstract January 1, 2014

Might men diagnosed with metastatic prostate cancer benefit from definitive treatment of the primary tumor? A SEER-based study - Abstract January 1, 2014

Dendreon Corporation announces presentation of PROVENGE® (sipuleucel-T) data at the 2013 European Cancer Congress December 31, 2013

Metastatic castration resistant prostate cancer: Current strategies of management in the Middle East - Abstract December 31, 2013

Impact of PSA and DRE on histologic findings at prostate biopsy in Turkish men over 75 years of age - Abstract December 31, 2013

Fluorescence-enhanced robotic radical prostatectomy using real-time lymphangiography and tissue marking with percutaneous injection of unconjugated indocyanine green: The initial clinical experience in 50 patients - Abstract December 31, 2013

Superior quality of life and improved surgical margins are achievable with robotic radical prostatectomy after a long learning curve: A prospective single-surgeon study of 1552 consecutive cases - Abstract December 30, 2013

Page 1076 of 1434